Macquarie initiates coverage on Divi’s Labs, 3 CRDMO firms with up to 40% upside potential
The global brokerage firm highlights that Indian CDMO companies trade at a 2-year forward EV/EBITDA of 20x, compared to 16x ...
Business Wire7h
Kirby McInerney LLP Urges Investors in BioAge Labs, Inc. (BIOA) to Inquire About Their Rights in Class Action Lawsuit
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District ...
Opinion
The Times Leader10hOpinion
Big food wants to feed our protein obsession
Consequently, food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...
Medscape15h
Compounded GLP-1s: Navigating the Telemedicine Landscape and Ensuring Patient Safety
Are compounded GLP-1s safe? Dr Ro breaks down the risks, FDA concerns, and telemedicine's role in prescribing these meds — what physicians must know to protect their patients.
Princeton University17h
The partnership that drives America’s leadership in medical discovery: How it works and what’s at stake
With federal support, universities produce world-changing discoveries and the next generation of exquisitely well-trained ...
Le Lézard23h
Employer-Sponsored GLP-1 Coverage Becomes Critical for Talent Retention and Acquisition, New 9amHealth Survey Finds
As the demand for GLP-1 weight loss medications such as Ozempic, Wegovy, and Zepbound continues to skyrocket, new survey results from 9amHealth reveal that access to these medications has become a ...